Anticancer agent 280

• Description:

  Anticancer agent 280 (Compound 65) is an anti-cancer agent targeting triple-negative breast cancer (TNBC) . Anticancer agent 280 exhibits IC50 values of Anticancer agent 280 for MDA-MB-231, MDA-MB-231/LM2-4, Jurkat, and MCF-7 of 7.1, 11.65, 6.99, and 21.51 μM respectively. Anticancer agent 280 can cause significant arrest of cells in the S phase and induce cell apoptosis. Anticancer agent 280 can be used for the study of TNBC[1].

• UNSPSC:

  12352005

• Target:

  Apoptosis

• Related Pathways:

  Apoptosis

• Field of Research:

  Cancer

• Smiles:

  O=C(C1=CN(C2=C(C1=O)C=C(C=C2)OC3=CC=CC=C3)CC4=CC=C(C=C4)C(F)(F)F)NCC5=CC=CC=C5

• Molecular Formula:

  C31H23F3N2O3

• Molecular Weight:

  528.52

• References & Citations:

  [1]Azzman N, et al. Novel 4-quinolone derivative inflicted cytotoxicity via intrinsic apoptotic pathway activation on human metastatic triple-negative breast cancer cells. Bioorg Chem. 2025 Oct;165:109033.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported